Search - tctmd.com

Displaying 101 - 120 of 806

Sort: Relevancy | Date

Presentation TCT 2021

TIDES-ACS: Three-Year Outcomes From a Randomized Trial of Titanium Nitride Oxide-Coated Versus Everolimus-eluting Stents in Patients With Acute Coronary Syndromes

Presenter: Pasi Karjalainen

November 06, 2021

Presentation TCT 2021

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

Presenter: IN-HO CHAE

November 06, 2021

Presentation TCT 2021

BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease

Presenter: Eline Ploumen

November 06, 2021

Presentation TCT 2021

Case 3: Planned Two Stents and Why I Chose This Two-Stent Technique

Presenter: Sahil Khera

November 04, 2021

Presentation TCT 2021

Case 2: Provisional Ending With Two Stents

Presenter: Katherine Kunkel

November 04, 2021

Presentation TCT 2021

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

Presenter: Rafael Romaguera

November 04, 2021

Presentation Fellows 2021

My Complications: more cases, more problems

Presenter: Kate Kearney

May 09, 2021

The OPTIMIZE IDE: TrialProspective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presentation TCT 2020

OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presenter: Dean J. Kereiakes

October 17, 2020

Presentation TCT 2020

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Presenter: Hyo-Soo Kim

October 17, 2020

Presentation TCT 2020

TCT 649: Self-Apposing Stents in Saphenous Vein Graft Angioplasty and Rotastent: Utility of Bi-Distal and 8Fr-Sheathless Transradial Access

Presenter: Hector Hugo Escutia-Cuevas

October 14, 2020

Presentation TCT 2020

TCT 305: Impact of Lesion Location on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug Eluting Stents for Unprotected Left Main Coronary Artery Stenosis

Presenter: David Power

October 14, 2020

Presentation TCT 2020

TCT 238: One Year Clinical Outcomes of Ultrathin Biodegradable Polymer Coated Sirolimus Eluting Stents in Total Occlusion: A Multicentre, All-Comer Analysis

Presenter: Prakash Ajmera

October 14, 2020

Presentation TCT 2020

TCT 167: Comparison of Stent Expansion Between Xience and Orsiro Stents in Heavily Calcified Coronary Arteries in Cadaver Heart

Presenter: Yu Sato

October 14, 2020

Presentation TCT 2020

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

Presenter: Wojciech Wanha

October 14, 2020

Presentation TCT 2020

TCT 266: Cobalt Chromium Biolimus Drug-Eluting Stents Compared With Stainless Steel Biolimus Drug-Eluting Stents: Final Results of BMX Alpha

Presenter: Ian Brian Alexander Menown

October 14, 2020

Presentation TCT 2020

TCT 276: A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer-coated Ultra-thin Everolimus-eluting Stents: 3-year Results from the PERFORM-EVER Registry

Presenter: Sridhar Kasturi, MD

October 14, 2020

Presentation TCT 2020

TCT 163: Risk of Coronary Artery Bypass Graft in the 10 Years After Drug Eluting Stents

Presenter: Parth Parikh

October 14, 2020

Presentation TCT 2020

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

Presenter: Jose de la Torre Hernandez

October 14, 2020

Presentation TCT Abstracts Posters 2019

A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer Coated Ultra-Thin Everolimus-Eluting Stents: One-year Results From the PERFORM-EVER Registry

Presenter: Sridhar Kasturi

October 09, 2019

Presentation TCT 2019

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

Presenter: Antonio Colombo

September 28, 2019

Advertisement

TIDES-ACS: Three-Year Outcomes From a Randomized Trial of Titanium Nitride Oxide-Coated Versus Everolimus-eluting Stents in Patients With Acute Coronary Syndromes

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease

Case 3: Planned Two Stents and Why I Chose This Two-Stent Technique

Case 2: Provisional Ending With Two Stents

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

My Complications: more cases, more problems

OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

TCT 649: Self-Apposing Stents in Saphenous Vein Graft Angioplasty and Rotastent: Utility of Bi-Distal and 8Fr-Sheathless Transradial Access

TCT 305: Impact of Lesion Location on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug Eluting Stents for Unprotected Left Main Coronary Artery Stenosis

TCT 238: One Year Clinical Outcomes of Ultrathin Biodegradable Polymer Coated Sirolimus Eluting Stents in Total Occlusion: A Multicentre, All-Comer Analysis

TCT 167: Comparison of Stent Expansion Between Xience and Orsiro Stents in Heavily Calcified Coronary Arteries in Cadaver Heart

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

TCT 266: Cobalt Chromium Biolimus Drug-Eluting Stents Compared With Stainless Steel Biolimus Drug-Eluting Stents: Final Results of BMX Alpha

TCT 276: A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer-coated Ultra-thin Everolimus-eluting Stents: 3-year Results from the PERFORM-EVER Registry

TCT 163: Risk of Coronary Artery Bypass Graft in the 10 Years After Drug Eluting Stents

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer Coated Ultra-Thin Everolimus-Eluting Stents: One-year Results From the PERFORM-EVER Registry

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content